In 2012, an estimated $245 billion was spent on diagnosed diabetes, according to a report released in Diabetes Care by the American Diabetes Association. That breaks down to $176 billion in direct medical costs and $69 billion in reduced productivity.
Hospital inpatient care accounted for 43 percent of the total medical cost, followed by prescription medications to treat diabetes complications (18 percent), antidiabetic agents and diabetes supplies (12 percent), physician office visits (9 percent), and nursing/residential facility stays (8 percent), according to the report.
“Increased prevalence, not increased cost per patient, is the driving force behind the increased economic burden of diabetes,” a Diabetes Care article reads. “Our continued improvement in diabetes care with progressive reductions in chronic complications of myocardial infarction, stroke, renal failure, and amputation reduces the per patient costs of the single greatest contributor to diabetes costs: hospitalizations.”
More articles on diabetes:
Cerner, Livongo Health partner for diabetes management
Treating, not boarding, mental health patients in emergency departments
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.